Hyderabad: Hyderabad headquartered Granules India announced that Granules Pharmaceuticals Inc (GPI), a wholly-owned foreign subsidiary of the company in Virginia, received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA). The GPI facility was inspected by the USFDA from January 24 to 28 for two of its product applications filed. There […]
